News

Cidara Therapeutics Gears Up for Upcoming Biotech Conference

Cidara Therapeutics Gears Up for Upcoming Biotech Conference

Cidara Therapeutics Gears Up for Upcoming Biotech Conference

Cidara Therapeutics, Inc. (NASDAQ: CDTX), based in San Diego, is making waves in the biotechnology sector with its innovative proprietary platform known as Cloudbreak. This platform specializes in developing drug-Fc conjugate (DFC) immunotherapies with a mission to enhance the standard of care for patients facing severe health challenges. Recently, the company announced an exciting opportunity: its President and CEO, Jeffrey Stein, Ph.D., is set to participate in an influential biotech conference.

Event Details

The event is the Guggenheim Securities SMID Cap Biotech Conference, a notable gathering for investors interested in small and mid-cap biotechs. The conference is scheduled for February and will feature a variety of discussions and presentations.

Conference Format

The format will include a fireside chat, creating an engaging environment for dialogue. This setting typically allows for more in-depth discussions on strategy, innovation, and market trends.

Watch the Presentation

For those interested in the conversation, a webcast will be available. This unique feature ensures that even those unable to attend in person can still experience the insights shared at the conference. The replay of this presentation will be accessible on Cidara's Investor page for 90 days.

Investors Interested in One-on-One Meetings

In addition to the conference presentation, Cidara will engage in one-on-one meetings with potential investors, making it a prime opportunity for stakeholders to directly connect with the company. Interested parties are encouraged to reach out to their Guggenheim representatives to schedule these discussions.

Cidara's Drug Development Pipeline

Cidara has made significant strides in their drug development pipeline, particularly with their lead DFC candidate, CD388. This innovative treatment aims to revolutionize antiviral care by providing universal prevention for seasonal and pandemic influenza. The company's focus on efficiency and effectiveness in immunotherapy development positions it as a leader in biotechnology.

Regulatory Recognition

The U.S. Food and Drug Administration (FDA) granted Fast Track Designation for CD388, recognizing its potential as a crucial tool in combating influenza. This approval can expedite the development timeline, emphasizing the promise that Cidara's research holds.

Oncology Ventures

Furthermore, Cidara is also exploring avenues in oncology, with another DFC project, CBO421, which recently received Investigational New Drug (IND) clearance. Designed to target CD73 in solid tumors, this project further showcases Cidara's commitment to expanding its therapeutic reach.

About Cidara Therapeutics

Founded on innovative ideas, Cidara aims to bridge gaps in treatment by utilizing its Cloudbreak platform for developing targeted, effective medications. The company remains dedicated to improving patient outcomes through advanced research and collaborations.

Investor and Media Contact Information

For those seeking further information, Cidara's investor contact is Brian Ritchie from LifeSci Advisors. He can be contacted at (212) 915-2578 or by email. Media inquiries should be directed to Michael Fitzhugh at LifeSci Communications, also available via email.

Frequently Asked Questions

What is the purpose of the Guggenheim Securities SMID Cap Biotech Conference?

The conference serves as a platform to showcase small to mid-cap biotech firms, offering insights into their research and investment opportunities.

Who will represent Cidara Therapeutics at the conference?

Jeffrey Stein, Ph.D., the President and CEO of Cidara Therapeutics, will be participating in discussions at the conference.

Where can I watch the webcast of the conference presentation?

The webcast will be available on Cidara's Investor page, allowing for remote access to the presentation.

What is the significance of Cidara's CD388 candidate?

CD388 is designed for universal prevention of influenza, with Fast Track Designation granting it potential expedited review by the FDA.

How can investors arrange a meeting with Cidara representatives?

Investors interested in meetings should contact their Guggenheim representative directly to arrange discussions with Cidara's team.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 87

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 158

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
NCPDP Elevates J.W. Hill to President & COO Role

Updated Category News Views 46

Plotting the Course for NCPDP's Future Today's shakeup at the NCPDP has got the sector's ears perked. For those who don't speak in acronym soup all day—NCPDP stands for National Council for Prescription Drug Programs. They're the brains behind many crucial healthcare standards, improving information flow around meds, supplies, and services. Now, they're taking bold...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 73

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 104

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 103

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 173

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 102

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Lululemon Faces Class Action: Navigating Investor Impact

Updated Category News Views 65

Lululemon's Legal Storm: Understanding the Background If you thought the yoga gear game was all about stretch and flexibility, Lululemon Athletica, Inc (NASDAQ: LULU) just yanked us back to reality. The company finds itself in a legal tangle with its shareholders following a dismal performance report and a subsequent lawsuit. This situation has unfolded like a second-rate...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Organizations: RockDove Solutions on Crisis Communication

Updated Category News Views 111

Understanding the Importance of Crisis Communication Plans In today's fast-paced world, effective crisis communication is more critical than ever for businesses. Surprisingly, fewer than half of U.S. companies have formal crisis communication strategies in place. This statistic highlights a significant gap in business continuity planning, where communication often...

Continue Reading
Hafnia Limited Reports Strong Earnings for Q3 2024 Period

Updated Category News Views 83

Hafnia Limited Reports Strong Earnings for Q3 2024 Period Hafnia Limited (“Hafnia” or “the Company”, OSE ticker code: “HAFNI”, NYSE ticker code: “HAFN”), a premier product tanker company with an extensive and modern fleet exceeding 130 vessels, has recently reported promising financial results for the three and nine months ended September 30, 2024. Key...

Continue Reading
Recent Shareholding Changes at Irish Continental Group PLC

Updated Category News Views 138

Understanding Director and PDMR Shareholding Notifications In the world of corporate governance, transparency plays a crucial role in maintaining trust, particularly when it comes to senior management and directors. Recent notifications reveal key transactions involving persons discharging managerial responsibilities (PDMRs) at Irish Continental Group plc. Overview of...

Continue Reading
Experience the Summer Vibes at Coastal Mississippi Events

Updated Category News Views 220

Summer Events in Coastal Mississippi Come Play Coastal all summer long with seafood feasts, fireworks, car shows, and more! Ready to turn up the fun this summer? Coastal Mississippi is bringing a thrilling lineup of unforgettable events, all set against the backdrop of 62 miles of beautiful shoreline. From fresh seafood to electrifying fireworks, sensational car shows,...

Continue Reading
GUNNAR Optiks and 2K Games Unveil Exciting New Glasses

Updated Category News Views 197

GUNNAR Optiks Partners with 2K Games for New Glasses GUNNAR Optiks, a frontrunner in combating digital eye strain and a pioneer in blue light blocking eyewear, has teamed up with 2K Games to introduce an exciting new collection inspired by the much-anticipated Borderlands 4. This striking collection unveils its first eyewear style, aptly named the Ripper, marking the...

Continue Reading